Veru Inc. (VERU) stock
VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
$2.14+0.06 (+2.88%)
Close on Nov 17, 2026Market cap $36.49MP/E –Yield –
Veru profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Veru's profit margin for the twelve months ending Sep 30, 2024 was -223.9%. For fiscal 2024 it was -223.9%, against -571.6% the year before. The highest annual figure on record is 29081.9% in fiscal 2011.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Sep 30, 2024 | -223.9% | +347.7 |
| FY2023 | Sep 30, 2023 | -571.6% | −358.0 |
| FY2022 | Sep 30, 2022 | -213.5% | −225.6 |
| FY2021 | Sep 30, 2021 | 12.1% | +56.6 |
| FY2020 | Sep 30, 2020 | -44.5% | −6.8 |
| FY2019 | Sep 30, 2019 | -37.8% | +113.1 |
| FY2018 | Sep 30, 2018 | -150.9% | −102.5 |
| FY2017 | Sep 30, 2017 | -48.4% | −50.0 |
| FY2016 | Sep 30, 2016 | 1.6% | −11.8 |
| FY2015 | Sep 30, 2015 | 13.3% | +3.4 |
| FY2014 | Sep 30, 2014 | 9.9% | −35.7 |
| FY2013 | Sep 30, 2013 | 45.6% | +1.9 |
| FY2012 | Sep 30, 2012 | 43.7% | −29038.2 |
| FY2011 | Sep 30, 2011 | 29081.9% | +29051.6 |
| FY2010 | Sep 30, 2010 | 30.3% | +6.6 |
| FY2009 | Sep 30, 2009 | 23.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -128.2% | +82.4 |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -277.4% | +97.4 |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -242.4% | +270.6 |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -386.6% | +1156.9 |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -210.6% | +1384.4 |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -374.8% | −143.6 |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -513.0% | −404.2 |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -1543.5% | −1498.4 |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -1594.9% | −1567.5 |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -231.2% | −215.9 |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -108.8% | −87.5 |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | -45.1% | −163.0 |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -27.4% | +73.3 |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -15.3% | +14.1 |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -21.3% | −13.2 |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | 117.9% | +149.1 |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -100.7% | −65.6 |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -29.3% | −0.8 |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -8.2% | +49.7 |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -31.2% | +2.5 |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | -35.1% | +117.1 |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -28.5% | +115.6 |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | -57.8% | +91.1 |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -33.7% | +130.9 |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -152.2% | −79.6 |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | -144.1% | −125.8 |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -148.9% | −75.1 |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -164.6% | −122.5 |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -72.6% | −23.4 |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -18.3% | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -73.9% | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -42.1% | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -49.1% | – |
See a number that looks wrong?